학술논문

Efficacy of first-line (1L) nivolumab (N) plus ipilimumab (I) by tumor histologic subtype in patients ( pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)
Document Type
Journal
Source
JOURNAL OF THORACIC ONCOLOGY; APR 2023, 18 4, pS64-pS65, 2p. Supplement: S
Subject
Language
English
ISSN
15561380